Pfizer has said its maternal vaccine couldpreventup to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV if the shot becomes available in the U.S. this fall and winter. "This fall marks the start of the annual respiratory infection season in the Northern Hem...
Last year, RSV alsoappeared earlier than usual, spiking in October before declining in November. At the time,experts told ABC Newsthat this might have occurred because children were not exposed to potential infection between 2020 and 2022 due to lockdowns, or because they were...
FRIDAY, Sept. 24, 2021 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Thursday recommended booster shots of Pfizer's coronavirus vaccine for millions of older and high-risk Americans, kicking off a new chapter in the national effort to protect the vulnerable from...
GSK's vaccine, called Arexvy, and Pfizer's vaccine, called Abrysvo, target a protein from the virus called the F protein that RSV uses to attach to human cells and infect people. The vaccine stimulates antibodies against the protein and protects against infection. GSK's shot...
its age extension application through the FDA approval process. The agency is currently reviewing an application from Pfizer to extend the license for its RSV vaccine, Abrysvo, to include adults 18 and older who have health conditions that put them at risk of severe illness from RSV infection....
Adults who are 60 years and older can get an RSV vaccine and pregnant women who are in their third trimester can get an RSV shot that provides protection against RSV to their baby for the first 6 months of life. Babies less than 8 months old who are born to mother...
Thompson, Dennis
“The data we will publish today and next week demonstrate the vaccine effectiveness against SARS CoV-2 infection is waning,” CDC DirectorRochelle Walenskysaid during a press briefing. “And even though our vaccines are currently working well to prevent hospitalizations, we are seeing concer...
The vote to recommend the vaccine was 11 to 1. The specific question advisers voted on was: “Maternal RSV vaccine is recommended for pregnant people during 32 through 36 weeks gestation, using seasonal administration, to prevent RSV lower respiratory tract infection in infants.” The vaccine, na...
Walensky said that even when the vaccine doesn’t closely match the circulating flu strains, “We see a 35% decrease in rates of hospitalization … which really just emphasizes, when we do have a good match, how much more effective it will be.” ...